Problem to solve and market to address
FUS already demonstrated its ability to perform non-invasive surgical procedures but with significant issues in target precision and applicability. Hence, to allow widespread diffusion of this therapeutic strategy, new paradigms in system architecture must be developed. FUTURA aims at overcoming the current issues, thus speeding up the translation into market of a real autonomous and non-invasive therapeutic platform.
European Union has a leading position in robotics and good potentials in FUS, which have not yet been combined so far. FUTURA could contribute to position the European Community as a reference for the FUS research and clinics worldwide. Furthermore, FUTURA aims at improving the quality of life of a large number of European citizens, as well as having positive consequences on the healthcare as a whole.
Why FUTURA now
The interest on innovative technologies for medicine has never been so high; the road for a future in which multi-robotic platforms performing scarless intervention has been traced. It is important to seize the day to move towards this final objective for maintaining a high level of technology and for translating promptly this technology to the healthcare systems.
Why FUTURA with this Consortium
The objectives of FUTURA are very ambitious and they require a strong Consortium to achieve the proposed results. The selected partners guarantee that all the required competences are covered by European leaders in their respective sectors. The Coordinator and the Partners have long-lasting experience in the fields of interest for FUTURA and they have been involved in several European Projects on related topics. Finally, the Consortium shows a strong involvement of Small/Medium Enterprises (SMEs), each one with its own market related to the assigned tasks, thus guaranteeing a timing exploitation not only of the final result of the project, but also of intermediate and spin-off results.